Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028559 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones
A NA study, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT02028559: Active NA study, sponsored by University of Washington.
NCT02028559 is a NA study that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 172 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02028559, a NA study, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
This study tests moving kidney stones using focused ultrasound (referred to as ultrasonic propulsion). The study includes multiple population groups to investigate the ability of our technology to: a) move stone fragments to a location within the kidney to improve their chances of passage, and thus reduce the occurrence of additional symptomatic events and retreatment or b) move a symptomatic stone to relieve symptoms and pain.
Primary Outcome
Percentage of study participants for which stone motion was observed on the real-time ultrasound images.
Interventions
- DEVICE Propulse 1 with C5-2 probe
- DEVICE Propulse 1 with SC-X probe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2013-12-17 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What the registry record for NCT02028559 still lists
NCT02028559 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Propulse 1 with C5-2 probe is the first listed.
NCT02028559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02028559 about?
NCT02028559 is a clinical study titled "Safety and Effectiveness of the Ultrasonic Propulsion of Kidney Stones". This study tests moving kidney stones using focused ultrasound (referred to as ultrasonic propulsion). The study includes multiple population groups to investigate the ability of our technology to: a) move stone fragments to a location within the kidney to improve their chances of passage, and thus ...
What is the current status of trial NCT02028559?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2013-12-17. Estimated completion is 2026-05-31.
What interventions are being tested in trial NCT02028559?
The interventions under investigation include: Propulse 1 with C5-2 probe (DEVICE), Propulse 1 with SC-X probe (DEVICE).
Who is sponsoring clinical trial NCT02028559?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02028559's enrollment target sits among peer trials
172 612th of 2000 higher than 1,389 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI